ReviewFrontiers in pharmacology2020

Current Evidence of Interleukin-6 Signaling Inhibitors in Patients With COVID-19: A Systematic Review and Meta-Analysis.

Qi Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.